Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Combined fixed-dose tablet of darunavir and cobicistat can help reduce number of pills in a combination antiretroviral treatment regimen.

Published
12 hours ago
From
Janssen press release
U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Evotaz is coformulated to be one pill, once-daily, combining the protease inhibitor atazanavir, which is marketed as Reyataz (atazanavir 200 mg/300 mg) capsules, and cobicistat, a pharmacokinetic enhancer marketed by Gilead Sciences, Inc.

Published
12 hours ago
From
Bristol-Myers Squibb press release
African American people’s AIDS conspiracy beliefs best understood in terms of social anxiety and distrust, not ignorance

The idea that AIDS was created as part of a government-led conspiracy to decimate the African American population remains salient to a significant minority of black people,

Published
29 January 2015
By
Roger Pebody
Russia may face shortage of anti-AIDS drugs in 2015

Russia may face a shortage of anti-AIDS drugs in 2015 due to the current complex situation in the national economy and devaluation of the rouble, according to recent statements of Vadim Pokrovsky, head of the Russian Federal Research and Methodological Center for Prevention and Control of AIDS.

Published
29 January 2015
From
EATG
Déjà Vu – Claims of HIV Cures and Re-Treading Old Ground

A few days ago while in Abuja, I was surprised to hear the news presenter announce that a Federal High Court had “lifted the ban” on Dr Abalaka’s “vaccine” against HIV. I was struck by a number of things – an abiding discomfort at the quality of reporting on science and health matters in the Nigerian media; a sense of guilt that, in failing to tell our stories, younger Nigerians are at risk of repeating missteps of the past; and a fear that many, misled by the news item, may put their lives at risk.

Published
28 January 2015
From
Nigeria Health Watch
An HIV Doctor Tells You If Undetectable Really Is the New Negative

Does being undetectable change the way you talk about your HIV status? Can a person who is undetectable stop worrying about transmitting HIV? Joel Gallant, an HIV doctor at Southwest CARE Center in Santa Fe, New Mexico gives his view.

Published
28 January 2015
From
The Body
Antiretroviral Neurotoxicity May Cause Cognitive Problems

As many as 50% of those on combination antiretroviral therapy (cART) suffer from mild to moderate cognitive dysfunction. Antiretroviral medications themselves may be partly to blame for such neurocognitive problems, suggests a recent review of previous studies. But the authors of this review do not recommend that antiretroviral treatment be stopped.

Published
28 January 2015
From
The Body Pro
Smoking is the main cause of increased risk of heart attack in people with HIV

People living with HIV who smoke have an almost three-fold greater risk of heart attack than HIV-negative smokers, according to Danish data published online ahead of print

Published
28 January 2015
By
Roger Pebody
Adherence packaging battles HIV/AIDS in Africa, India

Designed to help prevent the spread of HIV/AIDS in sub-Saharan Africa and India, MEMSCap smart electronic medication packaging system tracks each time the medication bottle is opened.

Published
26 January 2015
From
Packaging World
Why scientific AIDS explanations struggle in townships

HIV/AIDS educators often seem to enjoy raising an eyebrow at outlandish beliefs over the disease. But in doing so they fail to realise that the joke is on them – these ideas continue to hold sway despite their best efforts.

Published
26 January 2015
From
Africa Check
← First12345...377Next →

Filter by country